Literature DB >> 3010843

Plasmid-mediated aminoglycoside phosphotransferases in Haemophilus ducreyi.

M J Sanson-le Pors, I M Casin, E Collatz.   

Abstract

Three clinical isolates of Haemophilus ducreyi, representing at least two subtypes, were shown to be resistant to streptomycin and kanamycin. They also produced a beta-lactamase and chloramphenicol acetyltransferase and were resistant to tetracycline. In the three strains the resistance to both aminoglycoside antibiotics was encoded by a plasmid of ca. 4.7 kilobases which apparently did not carry ampicillin, chloramphenicol, or tetracycline resistance genes, as determined after transfer to Escherichia coli by transformation. Resistance to streptomycin and kanamycin was due to the presence of two aminoglycoside phosphotransferases (APH). The enzyme modifying kanamycin was a 3',5"-APH of type I [APH(3',5")-I], as inferred from its substrate profile and immunological cross-reactivity with the APH(3',5")-I encoded by the transposable element Tn903. However, the APH(3',5")-I gene in H. ducreyi did not appear to be carried by Tn903.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3010843      PMCID: PMC180239          DOI: 10.1128/AAC.28.2.315

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  35 in total

1.  Drug of choice for chancroid.

Authors:  A W Sturm; H C Zanen
Journal:  Lancet       Date:  1983-01-15       Impact factor: 79.321

2.  Streptomycin-resistant Haemophilus ducreyi.

Authors:  V S Rajan; E H Sng
Journal:  Lancet       Date:  1982-11-06       Impact factor: 79.321

3.  The enzymatic profile of Haemophilus ducreyi.

Authors:  I M Casin; M J Sanson-Le Pors; M F Gorce; M Ortenberg; Y Pérol
Journal:  Ann Microbiol (Paris)       Date:  1982 Nov-Dec

4.  Tn1525, a kanamycin R determinant flanked by two direct copies of IS15.

Authors:  A Labigne-Roussel; S Briaux-Gerbaud; P Courvalin
Journal:  Mol Gen Genet       Date:  1983

5.  In-vitro susceptibility of thirty strains of Haemophilus ducreyi to several antibiotics including six cephalosporins.

Authors:  M J Sanson-Le Pors; I Casin; M Ortenberg; Y Perol
Journal:  J Antimicrob Chemother       Date:  1983-03       Impact factor: 5.790

6.  A dot-immunobinding assay for monoclonal and other antibodies.

Authors:  R Hawkes; E Niday; J Gordon
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

7.  Detection of chloramphenicol acetyltransferase (CAT) activity in a strain of Haemophilus ducreyi.

Authors:  M J Sanson-Le Pors; I M Casin; M Ortenberg; Y Perol
Journal:  Ann Microbiol (Paris)       Date:  1982 Sep-Oct

8.  Plasmid-mediated sulfonamide resistance in Haemophilus ducreyi.

Authors:  W L Albritton; J L Brunton; L Slaney; I MacLean
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

9.  Single-dose therapy of chancroid with trimethoprim-sulfametrole.

Authors:  F A Plummer; H Nsanze; L J D'Costa; P Karasira; I W Maclean; R H Ellison; A R Ronald
Journal:  N Engl J Med       Date:  1983-07-14       Impact factor: 91.245

10.  Outer membrane permeation of beta-lactam antibiotics in Escherichia coli, Proteus mirabilis, and Enterobacter cloacae.

Authors:  T Sawai; R Hiruma; N Kawana; M Kaneko; F Taniyasu; A Inami
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

View more
  8 in total

Review 1.  Antimicrobial susceptibility of Haemophilus ducreyi.

Authors:  Y Dangor; R C Ballard; S D Miller; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

2.  In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.

Authors:  M J Sanson-Le Pors; I M Casin; M C Thebault; G Arlet; Y Perol
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

3.  Transfer of amikacin resistance by closely related plasmids in members of the family Enterobacteriaceae isolated in Chile.

Authors:  G T Van Nhieu; F W Goldstein; M E Pinto; J F Acar; E Collatz
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

4.  Sulphaphenazole, streptomycin and sulphaphenazole combination, trimethoprim, and erythromycin in the treatment of chancroid.

Authors:  B Kumar; V K Sharma; V Bakaya
Journal:  Genitourin Med       Date:  1990-04

Review 5.  Chancroid and Haemophilus ducreyi: an update.

Authors:  D L Trees; S A Morse
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

6.  Novel plasmid combinations in Haemophilus ducreyi isolates from Thailand.

Authors:  S K Sarafian; S R Johnson; M L Thomas; J S Knapp
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

7.  Characterization of a multiple antibiotic resistance plasmid from Haemophilus ducreyi.

Authors:  P J Willson; W L Albritton; L Slaney; J K Setlow
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 8.  Chancroid and Haemophilus ducreyi.

Authors:  S A Morse
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.